"No medicine to do" will be the biggest problem faced by pharmaceutical manufacturers in 2020!

Do you think the biggest problem for pharmaceutical companies and agents is compliance? Wrong! Pharmaceutical companies do have pressure, and the pressure is high Agents are like baking on the fire every day The cost cannot be paid, the tickets cannot be opened, and the money cannot be obtained Manufacturers set up compliance departments one after another A group of young boys and girls are too busy to distribute the "evidence chain" for audit Agents are in conflict with each other, the financial director is gloomy, and the sales manager is not pleasing But the biggest problem, many people began to realize that there is no medicine at all! The compliance system can be gradually established through training, learning, adjustment and exploration, and practice and exploration, but there is no medicine to do The manufacturers and agents keep empty bowls and look at each other Do you let upstream and downstream manufacturers drink? Although there are only 25 varieties of 4 + 7 collection, the domino effect has appeared 25 varieties not only affect the same generic products, but also affect the varieties in the same treatment field For example, entecavir dispersible tablets, first-line anti hepatitis B drugs, are unanimously recognized by doctors and patients without education 0.5g * 21 tablets, the median price is 3.83 yuan Before the original research drug, a box of 5600 yuan, the price difference is so wide How do you explain the same lamivudine and adefovir dipivoxil to patients in the hospital? How to keep the high price of the same kind of products in drugstores? Not to mention some Chinese patent medicines whose curative effects cannot be self certified, a series of drug prices will collapse sooner or later Experts have estimated that a drug purchased with quantity can affect at least 4-5 drugs in the same field The purchase with quantity only needs 2-3 rounds, and 200-300 varieties commonly used in hospitals will be severely impacted by the price Therefore, the purchase volume of 4 + 7 centralized purchase is 1.9 billion, and the scope of centralized purchase is expanded to 3.369 billion In terms of volume, that is, the drug purchase volume of a big third class a hospital in Beijing and Shanghai in one year, but its purchase rules and use management have a huge impact on other varieties On the day of the price announcement, the stock market was in a terrible green The whole industry paid special attention to the small eyes, the entrants and the peripheral, which is the reason In the future, if the "986 1 + X mode (basic medicine allocation of grass-roots / secondary / tertiary hospitals shall not be less than 90% / 80% / 60%) is strictly implemented, the basic medicine will be the basic medicine After ensuring the basic medicine, the hospital will consider the non-basic medicine Moreover, the medical insurance is still removing local supplementary varieties In only three years, according to the transfer out rhythm of 40%, 40% and 20%, all the "big varieties" in the past will be basically eliminated Those who have not been killed are also under strict supervision in the hospital Clinical pathway, DRGs, prescription review, and the big varieties of the past are coming down the altar In this way, one variety after another is either squeezed out of price space or dying How many cards do you have? Most manufacturers are basically not good, right? It's a tragedy that the patient has no medicine to cure It's also a tragedy that the medicine man has done medicine all his life until he finally "has no medicine to do" In a large pharmaceutical factory, there are at least hundreds of employees who have no medicine to do What should these people do? Eat and die? It's still several years before we retire There are old people and small people We can't let the elders worry about it and let the children down At present, the fundamentals of the policy have been clear, all kinds of interpretation of the circle of friends 24 * 7 are overwhelming, if you still can't see the situation, it's really worth leaving the industry Policy is irreversible, complaints and excessive anxiety can't solve the problem, only to calm down and take a good inventory of the cards in your hands, how many can you play? If not, what should I do? The first thing you can do is to make sure there is a certain price space No space, no matter what marketing method, it will fail There is only one mode: channel sales Of course, it can be discussed whether this channel is a traditional commercial channel, a fast approval channel or an e-commerce channel, but the previous promotion methods will no longer exist and the profits will not be borne!